Semaglutide
Specific semaglutide prescription products are authorized in Canada; an ingredient name does not validate every seller, vial, formulation, route, or claim.
Canadian status checked August 2, 2026
Evidence Library
Peptide status, without shortcuts.
Plain-language profiles that separate the exact Canadian product status from research interest, online claims, and evidence quality.
Read status precisely. “Authorized” applies to an exact finished product and use. “Investigational” does not mean available. A research-use label does not authorize human use.
Unauthorized / investigational
Retatrutide
Retatrutide has human clinical-trial evidence but remains investigational; online products are not authorized substitutes for trial medication.
Canadian status checked August 2, 2026
Unauthorized / investigational
TB-500
Research involving thymosin beta-4 does not validate retail products labelled TB-500 or establish recovery benefits in people.
Canadian status checked August 2, 2026
Unauthorized / investigational
Ipamorelin
Ipamorelin changes growth-hormone signalling, but that mechanism does not establish the body-composition or recovery outcomes promoted online.
Canadian status checked August 2, 2026
Unauthorized / investigational
GHK-Cu
Topical cosmetic discussion about GHK-Cu does not establish the safety or authorization of injectable products.
Canadian status checked August 2, 2026
Unauthorized / investigational
CJC-1295
CJC-1295 is investigational; small pharmacology studies do not establish the consumer benefits promoted online.
Canadian status checked August 2, 2026
Unauthorized / investigational
BPC-157
BPC-157 is not a Health Canada-authorized treatment, and controlled human evidence remains very limited.
Canadian status checked August 2, 2026
No entries match that filter.